β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL

Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial

(2018) Manfred Ballmann et al.   Lancet Diabetes & Endocrinology

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

(2016) Saba Sheikh et al.   DIABETES

One-hour post-load plasma glucose level during the OGTT predicts dysglycemia

(2016) Michael Bergman et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension

(2016) M. Bergman et al.   DIABETIC MEDICINE

One-hour plasma glucose as a predictor of the development of Type 2 diabetes in Japanese adults

(2015) R. Oka et al.   DIABETIC MEDICINE

One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose

(2015) Teresa Vanessa Fiorentino et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Origins of Cystic Fibrosis Lung Disease

(2015) David A. Stoltz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Elevation of one hour plasma glucose during oral glucose tolerance testing

(2015) Saba Sheikh et al.   PEDIATRIC PULMONOLOGY

Improvement in β-Cell Secretory Capacity After Human Islet Transplantation According to the CIT07 Protocol

(2013) Michael R. Rickels et al.   DIABETES

Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study

(2013) Cristina Bianchi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)

(2011) R. C. Loopstra-Masters et al.   DIABETOLOGIA

Epidemiology, Pathophysiology, and Prognostic Implications of Cystic Fibrosis-Related Diabetes: A technical review

(2010) A. Moran et al.   DIABETES CARE

Clinical Care Guidelines for Cystic Fibrosis-Related Diabetes: A position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society

(2010) A. Moran et al.   DIABETES CARE

Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis

(2009) E. Succurro et al.   ATHEROSCLEROSIS

Cystic Fibrosis-Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality

(2009) A. Moran et al.   DIABETES CARE

One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes

(2008) M. A. Abdul-Ghani et al.   DIABETES CARE

Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results from the Botnia Study

(2008) M. A. Abdul-Ghani et al.   DIABETES CARE

Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report

(2008) Philip M. Farrell et al.   JOURNAL OF PEDIATRICS